Related Experiment Video

Updated: Jul 31, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia

S Sanyal1, P R Smith, A C Saha

  • 1Department of Internal Medicine, the Long Island College Hospital, and the Scientific/Academic Computing Center, SUNY Health Science Center at Brooklyn, New York, USA.

American Journal of Respiratory and Critical Care Medicine
|July 3, 1999
PubMed

Insights

Initial microbiologic studies may not be necessary for most community-acquired pneumonia (CAP) patients. This study found no benefit in guiding antibiotic changes for non-responders with CAP.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Clinical Microbiology

Background:

  • Community-acquired pneumonia (CAP) diagnosis often lacks a specific pathogen identification via microbiologic studies (MBSs).
  • Current guidelines recommend empirical antibiotic treatment based on illness severity and patient comorbidities.

Purpose of the Study:

  • To evaluate the utility of initial microbiologic studies in adult patients hospitalized with CAP and treated per American Thoracic Society Guidelines (ATS-GL).

Main Methods:

  • Retrospective analysis of 184 adult CAP patients hospitalized in 1996.
  • Patients were treated according to ATS-GL recommendations.
  • Outcomes were compared between patients with empirical antibiotic changes and those with MBS-guided changes for non-responders.

Main Results:

  • 14% (25 out of 184) of patients did not respond to initial antibiotic regimens.
  • No significant difference in mortality was observed between empirical and MBS-guided antibiotic adjustments in non-responders.
  • No specific pathogen was identified in over 50% of initial MBS.

Conclusions:

  • Initial microbiologic studies may not be essential for all hospitalized CAP patients.
  • Consider MBS for patients with conditions predisposing to resistant or uncommon pathogens.
  • Treatment decisions for CAP can often rely on clinical assessment and guidelines rather than routine initial microbiologic testing.

More Related Videos

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...